The US FDA has scheduled a Pharmacy Compounding Advisory Committee (PCAC) Meeting for Monday, February 23, 2015, to discuss revisions to the list of drugs that may or may not be compounded under the Food Drug & Cosmetic Act and creation of the list of bulk drug substances that may be used to compound drug products.